Clinical Trials Logo
  1. Home
  2. Chronic Back Pain
  3. NCT04571242

SCS Programming Study in Treating Intractable Chronic Back Pain (NOVA) — NOVA  

Chronic Back Pain Clinical Trial

Official title:
Open-Label, Post Market Study: Study the Effects of Differential Target Multiplexed Spinal Cord Stimulation (DTM™SCS) Programs in Treating Intractable Chronic Back Pain in Subjects Without Prior History of Spine Surgery

Clinical Trial Summary

This is an open-label prospective, randomized, controlled, multi-center study comparing DTM-SCS programming approach to Conventional SCS programming approach. The purpose of this investigational study is to study the effects of Differential Target Multiplexed Spinal Cord Stimulation (DTM-SCS) in subjects with chronic, intractable pain of the trunk with or without lower limb pain, including unilateral or bilateral pain without prior history of spine surgery and refractory to conservative and surgical interventions.

Clinical Trial Description

This is an open-label prospective, randomized, controlled, multi-center study comparing DTM-SCS programming approach to Conventional SCS programming approach. Subjects meeting study entrance criteria will be randomized in a 1:1 ratio to one of two study treatment groups: - Test treatment group with DTM-SCS programming approach - Control treatment group with Conventional SCS programming approach Data at follow-up visits will be compared between the two treatment groups, and in reference to baseline assessments collected at the beginning of the study. There is an optional two-way crossover to the other treatment group available for all subjects who remain implanted at 6 month visit. Up to 250 subjects may be enrolled at up to 20 clinical sites in the United States in order to include an estimated 135 subjects to the point of randomization. This would allow a minimum of 100 subjects (50% in each treatment arm) to complete the 3-month endpoint. The expected total duration of this study is approximately 32 months. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04571242
Study type Interventional
Source SGX Medical LLC
Contact
Status Completed
Phase N/A
Start date September 2, 2020
Completion date April 12, 2023
View Details
See also
  Status Clinical Trial Phase
Completed NCT01944150 - Association of Transcutaneous Electrical Nerve Stimulation and Hypnosis N/A
Recruiting NCT05220202 - MOTIVATE to Improve Outcomes for Older Veterans With Musculoskeletal Pain and Depression N/A
Active, not recruiting NCT05203770 - Adaptations of the Brain in Chronic Pain With Opioid Exposure I
Withdrawn NCT04082715 - Transition From Acute to Chronic Back Pain : Effect of L-dopa,Gender,and Associated Brain Plasticity Phase 2
Completed NCT04307446 - Immersive Virtual Reality and Chronic Back Pain N/A
Completed NCT03896035 - Improving Outcomes for Older Veterans With Chronic Back Pain and Depression N/A
Recruiting NCT05994118 - Physiological, Cognitive, and Personal Features in the Link Between Placebo-effect and Variability of Pain Reports N/A
Active, not recruiting NCT03312010 - Tsunami DRG High Frequency Stimulation Study N/A
Completed NCT05167214 - The Acute Effect Of Different Kinesiological Tape N/A
Recruiting NCT06288282 - Behavioral and Cognitive Predictors of Persistent Pain and Opioid Misuse in Chronic Pain
Recruiting NCT04270617 - The Effect of Yoga Practice on Chronic Back Pain N/A
Withdrawn NCT01631513 - An Open-label Evaluation of Tapentadol Extended Release (ER) in Participants With Moderate to Severe Chronic Pain After Conversion From Hydrocodone, Oxycodone Controlled Release (CR), and/or Morphine Sustained Release (SR) Phase 4
Completed NCT01766973 - Decoding Chronic Pain With fMRI
Completed NCT02375633 - Phase 3 Study of DW-330SR2 and Pelubiprofen in Chronic Back Pain Patients Phase 3